Multiple Myeloma | Pharmacor | G7 | 2015

launch Related Market Assessment Reports

• Multiple Myeloma – Landscape & Forecast – Disease Landscape & Forecast

  May 2023

  The multiple myeloma therapy market continues to grow, fueled by the disease’s increasing incidence and the long treatment durations. The availability of premium-priced branded agents prescribed…

• Multiple Myeloma – Epidemiology – Epidemiology Dashboard

  February 2023

  Clarivate Epidemiology's coverage of multiple myeloma comprises epidemiological estimates of key patient populations across 45 countries worldwide. We report both the incidence and prevalence…

• Multiple Myeloma – Epidemiology – Mature Markets

  Clarivate Epidemiology’s coverage of multiple myeloma comprises epidemiological estimates of key patient populations in 45 countries worldwide. We report both the incidence and prevalence of…

• Multiple Myeloma – Epidemiology – Emerging Markets

  Clarivate Epidemiology’s coverage of multiple myeloma comprises epidemiological estimates of key patient populations in 45 countries worldwide. We report both the incidence and prevalence of…

• Multiple Myeloma – Epidemiology – Americas

  Clarivate Epidemiology’s coverage of multiple myeloma comprises epidemiological estimates of key patient populations in 45 countries worldwide. We report both the incidence and prevalence of…